Free Trial

Jefferies Financial Group's Rating of Vicore Pharma on 10/9/2026

On October 9, 2026, Jefferies Financial Group updated its outlook on Vicore Pharma (NASDAQ:VCRE) with the action "Initiated Coverage", setting a "Buy" rating. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.

More Ratings from Jefferies Financial Group Inc.

DateCompanyAction
10/9/2026
Sunrun Inc. stock logo
RUN
Sunrun
Reiterated Rating
10/9/2026
Plains All American Pipeline Lp stock logo
PAA
Plains All American Pipeline
Initiated Coverage
10/9/2026
Imperial Brands PLC stock logo
IMB
Imperial Brands
Reiterated Rating
10/9/2026
Wickes Group plc stock logo
WIX
Wickes Group
Reiterated Rating
10/9/2026
Unite Group PLC stock logo
UTG
Unite Group
Reiterated Rating
10/9/2026
IG Group Holdings plc stock logo
IGG
IG Group
Reiterated Rating
More Ratings From Jefferies Financial Group Inc.